ULTRAVAC 7 IN 1 VACCINE

Država: Australija

Jezik: engleski

Izvor: APVMA (Australian Pesticides and Veterinary Medicines Authority)

Aktivni sastojci:

CLOSTRIDIUM CHAUVOEI - FORMOL CULTURE; LEPTOSPIRA INTERROGANS SEROVAR POMONA; LEPTOSPIRA BORGPETERSENII SEROVAR HARDJO; CLOSTRIDIUM NOVYI TYPE B - TOXOID; CLOSTRIDIUM PERFRINGENS TYPE D TOXOID; CLOSTRIDIUM SEPTICUM - TOXOID; CLOSTRIDIUM TETANI - TOXOID

Dostupno od:

ZOETIS AUSTRALIA PTY LTD

INN (International ime):

Cl perfringens toxoid (D)+Cl tetani - toxoid+Cl novyi type B + others

Farmaceutski oblik:

MISC. VACCINES OR ANTI SERA

Sastav:

CLOSTRIDIUM CHAUVOEI - FORMOL CULTURE VACCINE-MICROBIAL Active 0.0 P; LEPTOSPIRA INTERROGANS SEROVAR POMONA VACCINE-MICROBIAL Active 0.0 P; LEPTOSPIRA BORGPETERSENII SEROVAR HARDJO VACCINE-MICROBIAL Active 0.0 P; CLOSTRIDIUM NOVYI TYPE B - TOXOID VACCINE-TOXOID Active 0.0 P; CLOSTRIDIUM PERFRINGENS TYPE D TOXOID VACCINE-TOXOID Active 0.0 P; CLOSTRIDIUM SEPTICUM - TOXOID VACCINE-TOXOID Active 0.0 P; CLOSTRIDIUM TETANI - TOXOID VACCINE-TOXOID Active 0.0 P

Jedinice u paketu:

100mL; 250mL; 500mL; 50mL

Razred:

VM - Veterinary Medicine

Proizveden od:

ZOETIS AUSTRALIA

Terapijska grupa:

CATTLE | BEEF | BOS INDICUS | BOS TAURUS | BOVINE | BUFFALO | BULL | BULLOCK | CALF | COW | DAIRY COW | HEIFER | STEER

Područje terapije:

IMMUNOTHERAPY

Terapijske indikacije:

BLACK DISEASE | BLACKLEG | ENTEROTOXAEMIA (PULPY KIDNEY) | LEPTOSPIROSIS | MALIGNANT OEDEMA | TETANUS | CLOSTRIDIUM PERFRINGENS TYPE D | L. HARDJO | L. INTERROGANS | L. POMONA | L. TARASSOVI | TETANUS VACCINATION

Proizvod sažetak:

Poison schedule: 0; Withholding period: MEAT: Zero (0) days MILK: Zero (0) days Export Slaughter Interval (ESI): Zero (0) days; Host/pest details: CATTLE: [BLACK DISEASE, BLACKLEG, ENTEROTOXAEMIA (PULPY KIDNEY), LEPTOSPIROSIS, MALIGNANT OEDEMA, TETANUS]; Poison schedule: 0; Withholding period: WHP: Nil. ESI: Not Applicable; Host/pest details: CATTLE: [BLACK DISEASE, BLACKLEG, ENTEROTOXAEMIA (PULPY KIDNEY), LEPTOSPIROSIS, MALIGNANT OEDEMA, TETANUS]; Poison schedule: 0; Withholding period: ; Host/pest details: CATTLE: [BLACK DISEASE, BLACKLEG, ENTEROTOXAEMIA (PULPY KIDNEY), LEPTOSPIROSIS, MALIGNANT OEDEMA, TETANUS]; For the prevention of enterotoxaemia (pulpy kidney disease), tetanus, black disease, malignant oedema (blackleg like disease), blackleg, and leptospirosis in cattle. Prevents urinary shedding of named leptospires when used prior to natural exposure.

Status autorizacije:

Registered

Datum autorizacije:

2023-07-01

Uputa o lijeku

(
c
APPENDIX2
Australian Government
Australian Pesticides
and
Veterinary Medicines Authority
TEMPLATE FOR RELEVANT
LABEL
PARTICULARS (RLPs)
(Veterinary
Produ~s{o
Select appropriate:
Cl
New Product (include all applicable RLPs)
OR
IRl
Variation (highlight instructions that are
being varied). Approval no.
of label being
varied:
53276/1 [2,3,4]/0509
Signal heading:
Product name:
Active
constituent/s:
Statement
of
claims:
RLP
Approved
Net contents:
FOR ANIMAL TREATMENT ONLY
Ultravac® 7 in 1 Vaccine
Ct.
perfringens
type D;;, 5 IU/mL,
Ct.
tetani;;,
2.5 IU/mL,
C/.
novyi
type B
;;,3.51U/mL,
Ct.
septicum
;;,
2.5 IU/mL (as ultrafiltered toxoids),
Ct.
chauvoei
0.3 mUmL,
Leptospira interrogans
serovar
Pomona;;,
400x1 0
6
organisms/mL,
Leptospira borgpetersenii
serovar
Hardjo
type
Hardjobovis;;,
400x 10
6
organisms/mL (as formal cultures)
0.1
mg/mL Thiomersal added as a preservative
Ultravac
7in1
is used for the routine immunisation of cattle for the prevention
of enterotoxaemia (pulpy kidney disease), tetanus, black disease,
malignant
oedema (blackleg-like disease), blackleg and leptospirosis
in
cattle.
For the prevention
of
urinary shedding of the named leptospires
in
cattle when
used prior to natural exposure and to prevent the risk
of
human leptospiral
infection associated with the shedding
of
the named leptospires in the urine
and from the reproductive tract
of
cattle.
For the prevention of enterotoxaemia (pulpy kidney disease), tetanus,
black
disease, malignant oedema (blackleg-like disease), blackleg and
leptospirosis
in
cattle. Prevents urinary shedding
of
the named leptospires when used prior
to natural exposure and to prevent the risk of human leptospiral
infection
associated with the shedding of the named leptospires
in
the urine and from
the reproductive tract of cattle.
For the prevention
of
reproductive tract colonisation and placental and
foetal infection with
L.
Hardjo.
APVMA'f.Jo. 53276/60300
50mL, 100mL, 250
mL
and
500
mL
18 Wormald Street, Symonston ACT 2609
PO Box 6182, Kingston ACT 2604 Australia
Tel:
+6

Svojstava lijeka

PRODUCT NAME: ULTRAVAC
® 7 IN 1, COMBINED 5 IN 1 / LEPTO VACCINE FOR CATTLE
PAGE: 1 OF 5
THIS REVISION ISSUED: APRIL, 2010
MATERIAL SAFETY DATA SHEET
Issued by: Pfizer Australia Pty Ltd
Phone: [phone]
SECTION 1 - IDENTIFICATION OF CHEMICAL PRODUCT AND COMPANY
Pfizer Australia Pty Ltd
38-42 Wharf Road
West Ryde NSW 2114
Tel: [phone]
Fax: [phone]
____________________________________
PFIZER AUSTRALIA PTY LTD
A.B.N. 50 008 422 348
SUBSTANCE:
Water solution/suspension of bacterial toxoids.
TRADE NAME:
ULTRAVAC
® 7 IN 1, COMBINED 5IN1 / LEPTO VACCINE FOR CATTLE
OTHER NAMES:
_Cl. perfringens_ Type D, _Cl. tetani, Cl. septicum, Cl. novyi_ Type
B, _Cl. chauvoei, L. _
_hardjo, L. pomona_ Vaccine for Cattle
PFIZER MSDS CODE:
0087
PRODUCT USE:
For the prevention of clostridial and leptospirosis diseases in
cattle.
CREATION DATE:
DECEMBER, 2004
THIS VERSION ISSUED:
APRIL, 2010
and is valid for 5 years from this date.
SECTION 2 - HAZARDS IDENTIFICATION
STATEMENT OF HAZARDOUS NATURE
This product is classified as:
Not classified as hazardous according to the criteria of SWA
Australia.
Not a Dangerous Good according to the Australian Dangerous Goods (ADG)
Code.
RISK PHRASES:
Not Hazardous - No criteria found.
SAFETY PHRASES:
Not Hazardous - No criteria found.
SUSDP CLASSIFICATION:
None (Aust); S2 (NZ)
ADG CLASSIFICATION:
None allocated. Not a Dangerous Good.
UN NUMBER:
None allocated
E
E
E
M
M
M
E
E
E
R
R
R
G
G
G
E
E
E
N
N
N
C
C
C
Y
Y
Y
O
O
O
V
V
V
E
E
E
R
R
R
V
V
V
I
I
I
E
E
E
W
W
W
PHYSICAL DESCRIPTION & COLOUR
: Aqueous suspension.
ODOUR:
No data.
MAJOR HEALTH HAZARDS:
no significant risk factors have been found for this product.
P
P
P
O
O
O
T
T
T
E
E
E
N
N
N
T
T
T
I
I
I
A
A
A
L
L
L
H
H
H
E
E
E
A
A
A
L
L
L
T
T
T
H
H
H
E
E
E
F
F
F
F
F
F
E
E
E
C
C
C
T
T
T
S
S
S
INACTIVATED CULTURES AND TOXOIDS ARE NOT REGARDED AS PATHOGENIC IN
HUMANS.
INHALATION
SHORT TERM EXPOSURE:
Significant inhalation exposure is considered to be unlikely. The
spray mist may be
discomforting to the upper respiratory tract and lungs, and